Bandingkan Harga & Kinerja Nusantara Sawit Sejahtera Tbk. (NSSS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Nusantara Sawit Sejahtera Tbk. dan Organon Pharma Indonesia Tbk.: Nusantara Sawit Sejahtera Tbk. diperdagangkan di Rp800 (kapitalisasi pasar 19,64 T, volume 24 jam 5,37 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Nusantara Sawit Sejahtera Tbk. jauh lebih besar — sekitar 188,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| NSSS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 19,64 T | 104,4 M |
Volume | 5,37 jt | — |
Lot | 53,75 rb | — |
Perputaran | 4,24 M | — |
Harga Rata-rata | 788,88 | — |
Nilai Transaksi | 4,24 M | — |
Harga Ekuilibrium Indikatif | 800 | — |
Volume Ekuilibrium Indikatif | 537 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Nusantara Sawit Sejahtera Tbk.
PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Selengkapnya di halaman NSSS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
